There were 1,713 press releases posted in the last 24 hours and 393,057 in the last 365 days.

CPR-Therapeutics' Announces Dave Gaddy as Their First Chief Engineering Officer

CPR Therapeutics Inc. (CPR-T), an early-stage medtech startup company, announced that Dave Gaddy has joined as its first Chief Engineering Officer.

We are tremendously excited to have Dave’s expertise. His background in engineering and biomedical device development are a perfect fit for our technical and regulatory challenges.”
— Norman Paradis
PUTNEY, VERMONT, UNITED STATES, May 8, 2023/EINPresswire.com/ -- CPR Therapeutics Inc. (CPR-T), an early-stage medtech startup company funded by the N.I.H and N.S.F to develop the next generation technology for cardiopulmonary resuscitation, announced today that Dave Gaddy has joined the Company as its first Chief Engineering Officer.
CPR Therapeutics is developing multimodal cardiopulmonary resuscitation (CPR), a more effective form of automated mechanical CPR. Sudden cardiac arrest is the leading cause of death in western countries and there are currently no devices more effective than manual chest compressions. Intact survival after sudden cardiac arrest is below 10% in most communities.

Norman Paradis MD, CPR Therapeutic’s Founder and CEO said “We are tremendously excited to have Dave’s expertise. His background in engineering and biomedical device development are a perfect fit for our technical and regulatory challenges. Our chances of success increase significantly with him as a member of our team.”

Asked to share his perspective on CPR Therapeutics Inc. and his new position, Dave Gaddy responded “Although I have had the opportunity to develop a number of innovative medical devices at my previous positions, I have always wanted to be part of the initial leadership team at an early-stage company taking on a major problem with a potentially impactful new technology. CPR Therapeutics Inc. gives me just that opportunity and then some.”

Dr. Paradis went on: “Dave’s first priority will be our NIH-NSF testbed which we will use to elucidate the optimal pattern of multimodal CPR. And almost immediately, he will start project development for our first clinical device, a cathlab version of our core vest technology for early FDA 510K clearance.”

CPR Therapeutics Inc.
CPR Therapeutics Inc. is a medical device start-up company developing the first advanced technology automated CPR system that integrates and synchronizes multiple technological innovations into a single system that can be easily applied under emergency conditions. The Company believes that this technology will, for the first time, demonstrate clinically significant improvements in intact survival after sudden death. The largest killer in Western Countries. Info@CPRTherapeutics.com

DISCLAIMER: The information provided pertaining to CPR Therapeutics Inc. ("CPR-T" or the "Company"), its business assets, strategy and operations is for general informational purposes only and is not a formal offer to sell or a solicitation of an offer to buy any securities, options, futures, or other derivatives related to securities in any jurisdiction and its content is not prescribed by securities laws. Information contained in this presentation should not be relied upon as advice to buy or sell or hold such securities or as an offer to sell such securities. This presentation does not take into account nor does it provide any tax, legal or investment advice or opinion regarding the specific investment objectives or financial situation of any person. While the information in this presentation is believed to be accurate and reliable, CPR-T and its agents, advisors, directors, officers, employees and shareholders make no representation or warranties, expressed or implied, as to the accuracy of such information and CPR-T expressly disclaims any and all liability that may be based on such information or errors or omissions thereof. CPR-T reserves the right to amend or replace the information contained herein, in part or entirely, at any time, and undertakes no obligation to provide the recipient with access to the amended information or to notify the recipient thereof.

Christine Couturier
CPR Therapeutics Inc.
+1 802-387-2717
email us here
Visit us on social media:
LinkedIn